• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » AdvaMed’s Whitaker calls for pandemic cooperation

AdvaMed’s Whitaker calls for pandemic cooperation

May 6, 2020 By Tom Salemi

Preparation for future pandemics will require closer cooperation between the medtech industry and the U.S. government, according to Scott Whitaker, CEO and president of the trade group AdvaMed.

In an interview on the DeviceTalks Weekly podcast, Whitaker laid out steps he believes the federal government and medtech industry must take, including addressing medical device and supply stockpiles and strengthening supply chains. Above all, Whitaker said, any response is strongest when government and industry work together, a lesson learned early on when the U.S. Centers for Disease Control and Prevention attempted to roll out the first line of  COVID-19 diagnostic tests.

Critics of the Trump administration’s handling of the pandemic have pointed to the failure to roll out a diagnostic test early enough to slow the spread of the virus that has killed over 70,000 people in the US.

“One of the biggest mistakes or flaws was early on when the CDC sort of fumbled that first task,” Whitaker said. “That was not the private sector that bungled it. There weren’t mistakes made by the private-sector companies. There were mistakes made by career officials at CDC. And it’s not to criticize, it’s just to recognize the reality that it takes both of us be successful.

“You’re not going to solve a crisis or be prepared for a crisis if it’s government-owned,” Whitaker added. “It’s just not going to happen.”

The trade group leader gave the medtech industry high marks for its response to demands for critical medical equipment, calling it “frankly excellent.” Early reports of the pandemic certainly suggested ventilator and protective personal equipment supply could be a problem, but no one could anticipate the actual demand.

“I wouldn’t say at the beginning of this year I knew it was going to be this acute,” Whitaker said. “You got the sense in February [and early March] … that we were getting ready to get hit with something that could be potentially catastrophic.”

Efforts to meet that demand led to the Trump administration invoking the Defense Production Act (DPA). Whitaker said he was initially concerned that the government would use the act to take control of factories. But those fears have been unfounded so far and Whitaker credited the administration for using the DPA to make critical ventilator parts a higher-priority import.

“It allowed those products to get into the country more quickly and not get held up at ports of entry,” he said. “So that was a very good use of the DPA. My assessment now is they used it appropriately, but it’s still in place. This is not over. And I think we need to make sure we’re continuing that dialogue, so it’s not used in the wrong way.”

Asked to assess the federal government’s response, Whitaker — who worked on pandemic preparation as chief of staff for the U.S. Department of Health and Human Services under President George W. Bush — said he doesn’t tend to “look back and criticize, particularly in the middle of a crisis, but I’m not sure the U.S. government or any other government for that matter can be fully prepared for a pandemic with a novel virus. And that was the case here.”

“I think the honest answer is, we weren’t fully ready for it,” he said.

Whitaker added that he puts more weight on pandemic response than on preparation, and he credited the federal government with engaging with industry to meet the needs created by the pandemic. He specifically mentioned the FDA’s quick work to issue emergency use authorizations (EUAs)for devices and diagnostics and said AdvaMed will seek clarification on how EUAs will be considered after the crisis is over.

 

Filed Under: Business/Financial News, Device Talks Podcasts, Diagnostics, Distribution, Featured, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: AdvaMed, coronavirus, COVID-19, U.S. Centers for Disease Control and Prevention, U.S. Department of Health and Human Services

In case you missed it

  • EchoNous partners with Samsung on AI-guided ultrasound
  • RefleXion expands footprint through multi-system contract with Select Healthcare
  • Report: 3M faces losses of $100B in earplug lawsuits
  • Caregility, Eko partner to bring smart stethoscope to telehealth platform
  • Henry Schein makes $400M increase to share repurchase plan
  • Tandem Diabetes Care delivers 1 million insulin boluses using t:connect mobile app
  • CathVision closes $7.2M financing round for electrophysiology recording tech
  • Verily’s Onduo, Sword Health collaborate on virtual care
  • FDA clears expanded labeling for Preceptis Medical’s ear tube system
  • KeyCare raises $24M for virtual care platform
  • FDA says 44 more deaths have been reported in Philips ventilator recall
  • Paragonix reaches milestone of 2,000 organs preserved, transported for transplantation
  • Axonics expands IP portfolio with new patents
  • BD, Accelerate Diagnostics partner on rapid antibiotic testing
  • FDA clears VySpine’s VyPlate anterior cervical plate system
  • Technical Brief – “Understanding the Extensive OEM Benefits of Total Linear Motion Solutions.”
  • Exactech launches total hip arthroplasty system

RSS From Medical Design & Outsourcing

  • Owens & Minor and Allina Health partner on supply chain resiliency
    Owens & Minor (NYSE: OMI) and Minneapolis-based Allina Health are partnering on what they call a “unique integrated service model for supply chain resiliency.” An Owens & Minor distribution center that has been in operation for more than 25 years in Moundsview, Minnesota will serve as the integrated service center powering the model, the companies… […]
  • Chronic pain researchers say sound and electrical stimulation has treatment potential
    University of Minnesota researchers are using sound and electrical stimulation to treat chronic pain and other sensory disorders without pharmaceutical drugs. The combination of sound and stimulation activates the brain’s somatosensory cortex, according to a study on guinea pigs published in the Journal of Neural Engineering. Also known as the tactile cortex, the somatosensory cortex is… […]
  • What Laura Mauri learned from a ‘firestorm’ in her first months at Medtronic
    Dr. Laura Mauri faced a monumental moment with former Medtronic CEO Omar Ishrak shortly after she joined the company as VP of global clinical research and analytics. It was late 2018, and Mauri — who’s now an SVP and the chief scientific, medical and regulatory officer at Medtronic (NYSE: MDT) — was in a meeting… […]
  • Senators seek post-market FDA study of pulse oximeters and skin color
    Democratic U.S. senators are prodding the FDA to launch a post-market study of pulse oximeters due to unreliable performance for patients with dark skin. Pulse oximeters estimate blood oxygen levels (SpO2) and pulse rates in patients using infrared light — usually on a fingertip — at home or in clinical settings. Blood oxygenation is one… […]
  • TE Connectivity opens global medical device prototyping center in Ireland
    TE Connectivity (NYSE:TEL) today announced it opened its global Propelus Prototype Center for medical devices in Galway, Ireland. The $5 million rapid prototyping center was built into its existing manufacturing site in Galway and directly connects TE engineers with customers to reduce development time and increase speed to market for lifesaving and life-improving medical devices. Propelus… […]
  • Contract manufacturer Minnetronix Medical launches its first in-house product, MindsEye
    Minnetronix Medical has launched MindsEye, making it the first medical device that the contract developer and manufacturer has conceived and commercialized. St. Paul-based Minnetronix Medical’s MindsEye is the first expandable brain access port on the market. The FDA cleared the device under the 510(k) pathway in August 2020. The minimally invasive device gives neurosurgeons deep… […]
  • What’s next for Jennifer Fried after leaving Explorer Surgical?
    Explorer Surgical co-founder Jennifer Fried has resigned from the company after selling it to Global Healthcare Exchange in October. Fried announced her departure last week on LinkedIn, saying she’s preparing for her next professional chapter. “It’s bittersweet — I’m so proud of everything our team has built and accomplished,” Fried wrote. “The time has flown… […]
  • The 24 best medical device innovations of 2022
    The Galien Foundation recently announced its nominees of medical device innovations for its 2022 Prix Galien USA awards. There are 24 medical technologies nominated for the annual award this year, up from 18 nominees in 2021. The Galien Foundation’s annual Prix Galien awards highlight devices, biotechnology and pharmaceutical products designed to improve the human condition.… […]
  • FDA issues new COVID-19 testing guidance to avoid false negatives
    COVID-19 testing should be repeated following a negative result on any antigen test, the FDA said in a move that could increase demand for diagnostics manufacturers. The latest guidance from the federal health agency is for negative COVID-19 antigen test results regardless of the presence or absence of symptoms. The federal agency said recent studies… […]
  • Confluent Medical expands Costa Rica manufacturing footprint for nitinol, complex catheter production
    Confluent Medical Technologies this week announced the opening of its new addition to its Costa Rica manufacturing facility. The expansion adds 66,000 sq. ft to its large-scale manufacturing center of excellence in Alajuela, Costa Rica to expand Confluent’s capacity for nitinol component processing and complex catheter manufacturing. “Confluent has experienced consistent and strong growth in… […]
  • FDA’s breakthrough medical device designations tally nears 700
    Stewart Eisenhart, Emergo Group The US Food and Drug Administration has granted almost 700 designations over the past seven years under a voluntary program for expedited regulatory review of medical devices and combination products that facilitate more effective treatment or diagnosis of serious diseases. According to recent metrics published by FDA, the agency has issued a total of… […]

Primary Sidebar

DeviceTalks Weekly

August 12, 2022
DTW – Medtronic’s Mauri brings years of patient care to top clinical, regulatory, scientific post
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy